(Q46781546)

25 December 2017

title

Buprederm, a new transdermal delivery system of buprenorphine: pharmacokinetic, efficacy and skin irritancy studies (English)

1 reference

25 December 2017

1 reference

In Park

1

1 reference

25 December 2017

Dongwon Kim

2

1 reference

25 December 2017

Jindeog Song

3

1 reference

25 December 2017

Chang Hoon In

4

1 reference

25 December 2017

Seung-Wei Jeong

5

1 reference

25 December 2017

Sang Hun Lee

6

1 reference

25 December 2017

Bumchan Min

7

1 reference

25 December 2017

Dongho Lee

8

1 reference

25 December 2017

Sun-Ok Kim

9

1 reference

25 December 2017

publication date

1 February 2008

1 reference

25 December 2017

published in

Pharmaceutical Research

1 reference

25 December 2017

volume

25

1 reference

25 December 2017

issue

5

1 reference

25 December 2017

page(s)

1052-1062

1 reference

25 December 2017

Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-007-9470-6

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-007-9470-6

Agonist and antagonist properties of buprenorphine, a new antinociceptive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-007-9470-6

The animal pharmacology of buprenorphine, an oripavine analgesic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-007-9470-6

Development and validation of a sensitive analytical method for the simultaneous determination of buprenorphine and norbuprenorphine in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-007-9470-6

The abdominal constriction response and its suppression by analgesic drugs in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-007-9470-6

Regional brain measurement of Bmax and KD with the opiate antagonist cyclofoxy: equilibrium studies in the conscious rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-007-9470-6

The barrier function of the skin in relation to percutaneous absorption of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-007-9470-6

Buprenorphine: bell-shaped dose-response curve for its antagonist effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-007-9470-6

[Controlled study of the analgesic effect and tolerability of buprenorphine in cancer patients]

21 January 2018

1 reference

12 December 2020

Practice guidelines for transdermal opioids in malignant pain

1 reference

12 December 2020

Buprenorphine TDS: the clinical development rationale and results.

1 reference

12 December 2020

Review of current pharmacologic treatment of pain

1 reference

12 December 2020

Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors.

1 reference

12 December 2020

Cancer pain: an update of pharmacological approaches in pain therapy.

1 reference

12 December 2020

Buprenorphine and the transdermal system: the ideal match in pain management.

1 reference

12 December 2020

A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies

1 reference

12 December 2020

Effect of analgesic treatment on the physiological consequences of acute pain.

1 reference

12 December 2020

Buprenorphine: a reappraisal of its antinociceptive effects and therapeutic use in alleviating post-operative pain in animals.

1 reference

12 December 2020

Acute and chronic administration of clorazepate modifies the cell surface regulation of mu opioid receptors induced by buprenorphine in specific regions of the rat brain

1 reference

12 December 2020

Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Stable isotope method for studying transdermal drug absorption: the nicotine patch

1 reference

12 December 2020

Methods for In Vitro Percutaneous Absorption Studies IV: the Flow-Through Diffusion Cell

1 reference

12 December 2020

Analgesic effect of antidepressant drugs

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: role of receptor equilibration kinetics

1 reference

12 December 2020

Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein

1 reference

12 December 2020

Common animal models for spasticity and pain.

1 reference

12 December 2020

Sympathetic nervous system and pain: a clinical reappraisal

1 reference

12 December 2020

Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain

1 reference

12 December 2020

Methods for in vitro percutaneous absorption studies V: Permeation through damaged skin

1 reference

12 December 2020

Management of acute and postoperative pain

1 reference

12 December 2020

Acute opioid receptor desensitization and tolerance: is there a link?

1 reference

12 December 2020

P-glycoprotein mediates brain-to-blood efflux transport of buprenorphine across the blood-brain barrier

1 reference

12 December 2020

Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index

1 reference

12 December 2020

Endogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats

1 reference

12 December 2020

Buprenorphine: considerations for pain management

1 reference

12 December 2020

Buprenorphine: new pharmacological aspects.

1 reference

12 December 2020

Transdermal buprenorphine

1 reference

12 December 2020

Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 1).

1 reference

12 December 2020

Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia

1 reference

12 December 2020

Buprenorphine: a primer for emergency physicians

1 reference

12 December 2020

How to advance in treating pain with opioids: less myths--less pain

1 reference

12 December 2020

Animal models for transdermal drug delivery

1 reference

12 December 2020

Analgesic efficacy of peripheral opioids (all except intra-articular): a qualitative systematic review of randomised controlled trials

1 reference

12 December 2020

Comparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling

1 reference

12 December 2020

Transdermal buprenorphine in the treatment of chronic pain

1 reference

12 December 2020

Simultaneous determination of buprenorphine, norbuprenorphine, and buprenorphine-glucuronide in plasma by liquid chromatography-tandem mass spectrometry.

1 reference

12 December 2020

Chronic and cancer pain management

1 reference

12 December 2020

Weak opioids--an educational substitute for morphine?

1 reference

12 December 2020

Percutaneous penetration studies for risk assessment

1 reference

12 December 2020

Fentanyl abuse and dependence: further evidence for second hand exposure hypothesis

1 reference

12 December 2020

[Management strategies for the treatment of non malignant chronic pain in the elderly]

1 reference

12 December 2020

Activity and tolerability of buprenorphine after parenteral and sublingual administration

1 reference

12 December 2020

Pharmacokinetic analysis of enterohepatic circulation of buprenorphine and its active metabolite, norbuprenorphine, in rats

1 reference

12 December 2020

Sensitive determination of buprenorphine and its N-dealkylated metabolite norbuprenorphine in human plasma by liquid chromatography coupled to tandem mass spectrometry

1 reference

12 December 2020

Active transport of fentanyl by the blood-brain barrier.

1 reference

12 December 2020

Effect of P-glycoprotein inhibition on methadone analgesia and brain distribution in the rat.

1 reference

12 December 2020

10.1007/S11095-007-9470-6

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017